Cargando…
National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China
Tamoxifen has been successfully used for treating breast cancer and preventing cancer recurrence. Cytochrome P450 2D6 (CYP2D6) plays a key role in the process of metabolizing tamoxifen to its active moiety, endoxifen. Patients with variants of the CYP2D6 gene may not receive the full benefit of tamo...
Autores principales: | Lin, Guigao, Zhang, Kuo, Yi, Lang, Han, Yanxi, Xie, Jiehong, Li, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015788/ https://www.ncbi.nlm.nih.gov/pubmed/27603206 http://dx.doi.org/10.1371/journal.pone.0162361 |
Ejemplares similares
-
Correction: National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China
Publicado: (2016) -
Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach
por: Lin, Guigao, et al.
Publicado: (2015) -
Results of the National External Quality Assessment for Toxoplasmosis Serological Testing in China
por: Zhang, Kuo, et al.
Publicado: (2015) -
Molecular Genetics External Quality Assessment Pilot Scheme for Irinotecan-Related UGT1A1 Genotyping in China
por: Yi, Lang, et al.
Publicado: (2016) -
Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect
por: Zhang, Kuo, et al.
Publicado: (2017)